🇺🇸 FDA
Patent

US 9555090

Equine encephalitis virus vaccines and methods of using thereof

granted A61KA61K2039/525A61K2039/5252

Quick answer

US patent 9555090 (Equine encephalitis virus vaccines and methods of using thereof) held by The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases expires Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as repesented by the Secretary of Army, on behalf of the U.S. Army Medical Research Institute of Infections Diseases
Grant date
Tue Jan 31 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K2039/525, A61K2039/5252, A61K2039/5254, A61K2039/53